P15.18 NAUSEA AND EMESIS DURING NEUROONCOLOGICAL CHEMOTHERAPY - PROBLEM RESOLVED WITH ANY SETRONE?

BACKGROUND: Temozolomide, the most important chemotherapeutic agent used in neurooncology, has moderate emetogenic potential. With the introduction of ondansetron, the first 5HT3-antagonist on the market, most of us neurooncologists thought that the problem of nausea and emesis was resolved. Some pa...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Just, L., Rock, H., Strik, H.M.
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2014
Témata:
Poster Presentations
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4185657/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou174.297
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky